Moreover, cetuximab-AuNPs could be added to the standard chemotherapy and radiotherapy, where the enhanced uptake by specific targeting, and the subsequent improved efficacy of the therapeutic agents/radiation could be a viable approach for the treatment of cancers with EGFR overexpression [32,33,34,35,36,37,38,39,40]. This evidence concerns the gene EGFR and cancer.